Acknowledgement
본 기술동향 기고문은 한국전자통신연구원 연구운영비지원사업의 일환으로 수행되었음[20ZB1165, ICT 창의기술 개발].
References
- C. Bouton, "Bioelectronic medicine: molecular mechanisms," SRC/NSF Workshop on Microsyst for Bioelecton Med, IBM Conference Center, Washington, D.C., USA, Apr. 12-13, 2017.
- S. Mishra, "Electroceuticals in medicine-The brave new future," Indian Heart J., vol. 69, no. 5, 2017, pp. 685-686. https://doi.org/10.1016/j.ihj.2017.10.001
- B. J. Seicol et al., "Neuromodulation of metabolic functions: from pharmaceuticals to bioelectronics to biocircuits," J. Biol. Eng., vol. 13, 2019, Article no. 67.
- K. Devarakonda and S. Stanley, "Investigating metabolic regulation using targeted neuromodulation," Ann. New Yorl Academy Sci., vol. 1411, no. 1, 2018, pp. 83-95. https://doi.org/10.1111/nyas.13468
- K. Famm, "A-jump start for elelctroceuticals," Nature, vol. 496, no. 11, 2013, pp. 159-161. https://doi.org/10.1038/496159a
- R. Carnagarin et al., "Autonomic regulation of glucose homeostasis: a specific role for sympathetic nervous system activation," Curr. Diab. Rep., vol. 18, no. 11, 2018, doi: 10.1007/s11892-018-1069-2.
- P. S. Olofsson and K. J. Tracey, "Bioelectronic medicine: technology targeting molecular mechanisms for therapy," J. Intern. Med., vol. 282, no. 1, 2017, doi: 10.1111/joim.12624.
- G. de Lartigue, "Role of the vagus nerve in the development and treatment of diet-induced obesity," J. Physiol., vol. 594, no. 20, 2016, doi: 10.1113/JP271538.
- H. Divanovic et al., "Effects of electrical stimulation as a new method of treating diabetes on animal models: review," IFMBE Proc., vol. 62, 2017, doi: 10.1007/978-981-10-4166-2_38.
- B. Thorens, "Neural regulation of pancreatic islet cell mass and function," Diabetes Obes. Metab., vol. 16, 2014, pp. 87-95. https://doi.org/10.1111/dom.12346
- U. S. Food and Drug Administration, "VNS therapy system: FDA," premarket approval (PMA)-Depression (Online) (updated 2005).
- J. P. O'Reardon, P. Cristancho and A.D. Peshek, "Vagus nerve stimulation (VNS) and treatment of depression: to the brainstem and beyond," Psychiatry (Edgmont), vol. 3, no. 5, 2006, pp. 54-63.
- E. N. Marieb, "Human anatomy," 6th ed., Benjamin Cummings, 2010.
- L. K. McCorry, "Physiology of the autonomic nervous system," Am. J. Pharm. Educ., vol. 71, no. 4, 2007, Article no. 78, doi: 10.5688/aj710478.
- F. S. Routledge et al., "Improvements in heart rate variability with exercise therapy," Can. J. Cardiol., vol. 26, 2010, pp. 303-312. https://doi.org/10.1016/S0828-282X(10)70395-0
- A. Nesvold et al., "Increased heart rate vatiability during nondirective meditation," Eur. J. Prev. Cardiol., vol. 19, 2012, pp. 773-780. https://doi.org/10.1177/1741826711414625
- S. Breit et al., "Vagus nerve as modulator of the brain-gut axis in psychiatric and inflammatory disorders," Front Psychiatry, vol. 9, 2018, Article no. 44, doi:10.3389/fpsyt.2018.00044.
- B. Bonaz et al., "Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflamatory pathway," Neurogastroenterol Motil, vol. 25, no. 3, 2013, pp. 208-221. https://doi.org/10.1111/nmo.12076
- K. J. Tracey, "The inflamatory reflex," Nature, vol. 420, 2002, pp. 853-859. https://doi.org/10.1038/nature01321
- S. C. Payne, J. B. Furness and M. J. Stebbing, "Bioelectric neuromodulation for gastrointestinal disorders: effectiveness and mechanisms," Nat. Rev. Gastro. Hepat., vol. 16, no. 2, 2019, pp. 89-105. https://doi.org/10.1038/s41575-018-0078-6
- U. S. Food and Drug Administration, "VNS therapy system: FDA, premarket approval (PMA)-Epilepsy" (Online) (updated 1997).
- J. M. Morton et al., "Effect of vagal nerve blockade on moderate obesity with an obesity-related comorbid condition: the ReCharge Study," Obes. Surg., vol. 26, 2016, pp. 983-989. https://doi.org/10.1007/s11695-016-2143-y
- U. S. Food and Drug Administration, "Devices@FDA: Medtronic interstim sacral nerve stimulation therapy system" (Online) (updated 2011).
- L. V. Borovikova et al., "Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin," Nature, vol. 405, 2000, pp. 458-461. https://doi.org/10.1038/35013070
- F. A. Koopman et al., "Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis," Proc. Natl. Acad. Sci. USA, vol. 113, no. 29, 2016, pp. 8284-8289. https://doi.org/10.1073/pnas.1605635113
- World Health Organization, "Global Report on Diabetes," 2016.
- S. Trevitt, S. Simpson, and A. Wood, "Artificial pancreas device systems for the closed-loop control of type 1 diabetes: What systems are in development?" J. Diabetes Sci. Technol., vol. 10, no. 3, 2016, pp. 714-723. https://doi.org/10.1177/1932296815617968
- A. Haidar et al., "Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled cross over trial," Lancet Diabetes Endocrinol., vol. 3, 2015, pp. 17-26. https://doi.org/10.1016/S2213-8587(14)70226-8
- A. Guemes and P. Georgiou, "Review of the role of the nervous system in glucose homeostasis and future perspectives towards the management of diabetes," Bioelectron Med., vol. 4, 2018, doi: 10.1186/s42234-018-0009-4.
- C. M. Hales, "Prevalence of obesity among adults and youth: United States 2015-2016," NCHS Data Brief, vol. 288, 2017, pp. 1-8.
- E. A, Katsareli and G. V. Dedoussis, "Biomarkers in the Field of obesity and its related comorbidities," Expert Opin. Ther. Targets, vol. 18, 2014. pp. 385-401. https://doi.org/10.1517/14728222.2014.882321
- R. Kassir et al., "Effects of vagus nerve stimulation on weight loss and associated disorders: a therapeutic perspective," J. Med. Diagn Meth., vol. 3, 2014, doi: 10.4172/2168-9784.1000e110.
- M. L. Ganz et al., "Economic costs of over active bladder in the United States," Urology, vol. 75, 2010, pp. 526-532. https://doi.org/10.1016/j.urology.2009.06.096
- J. W. Boggs et al. "Frequency dependent selection of reflexes by pudendal afferents in the cat," J. Physiol., vol. 577, 2006, pp. 115-126. https://doi.org/10.1113/jphysiol.2006.111815
- X. Navarro et al., "A critical review of interfaces with the peripheral nervous system for the control of neuroprostheses and hybrid bionic systems," J. Peripher Nerv. Syst., vol. 10, 2005, pp. 229-258. https://doi.org/10.1111/j.1085-9489.2005.10303.x
- E. H. Rijnbeek, N. Eleveld, and W. Olthuis, "Update on peripheral nerve electrodes for closed-loop neuroprosthetics," Front Neurosci, vol. 12, 2018, doi: 10.3389/fnins.2018.00350.
- C. Russell, D. Roche, and S. Chakrabarty, "Peripheral nerve bionic interface: a review of electrodes," Int. J. Intell. Robot. Appl., vol. 3, 2019, pp. 11-18. https://doi.org/10.1007/s41315-019-00086-3
- S. Eldabe, E. Buchser, and R.V. Duarte, "Complications of spinal cord stimulation and peripheral nerve stimulation techniques: a review of the literature," Pain Med, vol. 17, 2016, pp. 325-336.
- V. H. Desai et al., "Chronic sensory-motor activity in behaving animals using regenerative multi-electrode interfaces," in Proc. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc., Chicago, IL, USA, Aug. 2014, pp. 1973-1976.
- X. A. Maul et al., "Microcurrent technology for rapid relief of sinus pain: a randomized placebo-controlled, double-blinded clinical trial," Int. Forum Allergy Rhinol., vol. 9, 2019, pp. 352-356. https://doi.org/10.1002/alr.22280
- K. Birmingham et al., "Bioelectronic medicines: a research roadmap," Nat. Rev. Drug Discov., vol. 13, 2014, pp. 399-400. https://doi.org/10.1038/nrd4351
- NIH, https://ncats.nih.gov/sparc
- S. F. Cogan et al., "Tissue damage thresholds during therapeutic electrical stimulation," J. Neural Eng., vol. 13, 2016, doi: 10.1088/1741-2560/13/2/021001.
- Reports and Data, "Electroceuticals / bioelectric medicine market analysis," 2019.
- Markets & Markets, "Electroceuticals / bioelectric medicine market by product (pacemakers, cochlear implants, spinal cord stimulators), type of device (implantable, non-invasive), application (arrhythmia, depression, migraine), end user (hospitals) - Global Forecast to 2021."
- Verified Market Research, "Global electroceuticals/ bioelectric medicine market size by type, by product, by application, by geographic scope and forecast," 2019.
- Alliance for Advancing Bioelectronic Medicine, "Building a bioelectronic medicine movement 2019: insights from leaders in industry, academia, and research," Bioelectron Med, vol. 6, 2020, 1.
- https://www/weforum.org /agenda/2018/09/top-10-emerging-technologies-of-2018.
- https://www.idtechex.com/en/research-article/six-firsts-inelectroceutical-approvals-of-2019/17604.